4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-21-011668
Exec. Director, Finance - PAO acquired 4,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Jones Michael L · Exec. Director, Finance - PAO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-18 | Exercise or conversion : show line 1 in the form | +4,500 | $3.51 | $15,795 | 5,348 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-18 | Exercise or conversion : show line 2 in the form Emp. Stock Option (Right to Buy) | −4,500 | 0 | D |
Loading xslF345X03/form4.xml…